Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-006557
Filing Date
2004-03-04
Accepted
2004-03-04 16:38:56
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2130007z10-k.htm 10-K 784690
3 EXHIBIT 10.13 a2130007zex-10_13.htm EX-10.13 179213
4 EXHIBIT 10.14 a2130007zex-10_14.htm EX-10.14 104873
5 EXHIBIT 23.1 a2130007zex-23_1.htm EX-23.1 3630
6 EXHIBIT 31.1 a2130007zex-31_1.htm EX-31.1 5701
7 EXHIBIT 31.2 a2130007zex-31_2.htm EX-31.2 5706
8 EXHIBIT 32.1 a2130007zex-32_1.htm EX-32.1 4494
9 EX1014IMAGE001.JPG ex1014image001.jpg GRAPHIC 16182
  Complete submission text file 0001047469-04-006557.txt   1106829
Mailing Address 4140 DUBLIN BLVD STE 200 DUBLIN CA 94568
Business Address 4140 DUBLIN BLVD SUITE 200 DUBLIN CA 94568 9255600100
SUPERGEN INC (Filer) CIK: 0000919722 (see all company filings)

EIN.: 911841574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27628 | Film No.: 04649247
SIC: 2834 Pharmaceutical Preparations